Reporte zur Charge CUS2096

Symptomtext

pain in my ankles; Pain is severe at times and greatly affects my mobility; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56-year-old male patient received bnt162b2 (BNT162B2), on 08Dec2021 at 09:00 as dose 3 (booster), single (Lot number: CUS2096) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: XELJANZ. Vaccination history included: bnt162b2 (Dose 2, lot unknown reason: not available), administration date: 04Mar2021, when the patient was 56-year-old, for COVID-19 immunization; covid-19 vaccine (Dose 1, dose lot unknown reason: not available), administration date: 25Mar2021, when the patient was 56-year-old, for COVID-19 immunization. The following information was reported: MOBILITY DECREASED (non-serious) with onset 12Feb2022 at 13:00, outcome "not recovered", described as "Pain is severe at times and greatky affects my mobility"; ARTHRALGIA (non-serious) with onset 12Feb2022 at 13:00, outcome "not recovered", described as "pain in my ankles". The events "pain in my ankles" and "pain is severe at times and greatly affects my mobility" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, mobility decreased.